within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A01A_StomatologicalPreparations.A01AB24_Octenidine;

model Octenidine
  extends Pharmacolibrary.Drugs.ATC.A.A01AB24;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A01AB24</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Octenidine is a cationic surfactant antiseptic used for skin, mucous membrane, and wound disinfection, particularly in Europe. It is utilized as an alternative to chlorhexidine or povidone-iodine for topical antisepsis, but is not used systemically and is not approved for internal use.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or quantitative systemic PK parameters exist, as octenidine is not intended or approved for systemic use. Antiseptic use is typically topical or oral rinse with negligible systemic absorption in healthy patients.</p><h4>References</h4><ol><li><p>Stahl, J, et al., &amp; Kietzmann, M (2011). The percutaneous permeation of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept®) through skin of different species in vitro. <i>BMC veterinary research</i> 7 44–None. DOI:<a href=\"https://doi.org/10.1186/1746-6148-7-44\">10.1186/1746-6148-7-44</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21835019/\">https://pubmed.ncbi.nlm.nih.gov/21835019</a></p></li><li><p>Stahl, J, et al., &amp; Kietzmann, M (2010). The effect of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept) on wound healing in pigs in vivo and its in vitro percutaneous permeation through intact and barrier disrupted porcine skin. <i>International wound journal</i> 7(1) 62–69. DOI:<a href=\"https://doi.org/10.1111/j.1742-481X.2009.00648.x\">10.1111/j.1742-481X.2009.00648.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20409252/\">https://pubmed.ncbi.nlm.nih.gov/20409252</a></p></li><li><p>Bührer, C, et al., &amp; Obladen, M (2002). Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation. <i>The Journal of hospital infection</i> 51(4) 305–307. DOI:<a href=\"https://doi.org/10.1053/jhin.2002.1249\">10.1053/jhin.2002.1249</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12183146/\">https://pubmed.ncbi.nlm.nih.gov/12183146</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Octenidine;
